Skip to main content

Drugs and the Respiratory System

  • Chapter
  • First Online:
Pharmacological Basis of Acute Care
  • 1662 Accesses

Abstract

The respiratory system serves as an important interface for gas exchange. It is vital to maintain the health of the airways to ensure a free flow of gases. Certain diseases that affect the airways and the gas exchange site are best treated with drugs delivered directly to the target sites via the inhalational route. This will not only result in immediate action but will keep the required drug dosages to the minimum and thus reduce their systemic side-effects. The non-inhalational mode is an alternative option when the passage to the gas exchange interface is too severely obstructed or if the drugs can only be given via the systemic route. There are two major classes of bronchodilators delivered via the inhalational mode in acute care, i.e., the beta 2 agonists and the anticholinergics. The two differ in both the onset of action as well as the duration of action. A combination of drugs from different classes is often employed in the acute situation to achieve the best bronchodilatory effect. Drug delivery for patients with poor inhalational technique can be assisted by means of a spacer or a nebulizer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  1. Barnes PJ. New therapies of COPD. Thorax. 1998;53:137–47.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2003;167(6):813–8.

    Article  PubMed  Google Scholar 

  3. Barnes PJ. New drugs for asthma. Nat Rev Drug Discov. 2004;3:831–44.

    Article  CAS  PubMed  Google Scholar 

  4. Dockhorn RJ, Baumgartner RA, Leff JA, Noonand M, Vandormaela K, Strickere W. Comparison of the effects of intravenous and oral Montelukast on airway function: a double-blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax. 2000;55:260–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Ferguson GT. Update on pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2000;21:723–38.

    Article  CAS  PubMed  Google Scholar 

  6. Jonsson S, Kjartansson G, Gislason D, Helgason H. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest. 1988;94:723–6.

    Article  CAS  PubMed  Google Scholar 

  7. Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ. 2001;322:1271–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticosteroids required in status asthmaticus? JAMA. 1988;260(4):527–9.

    Article  CAS  PubMed  Google Scholar 

  9. Rodrigo G, Rodrigo C, Burschtin O. Efficacy of magnesium sulfate in acute adult asthma: a meta-analysis of randomized trials. Am J Emerg Med. 2000;18:216–21.

    Article  CAS  PubMed  Google Scholar 

  10. Rolla G, Bucca C, Caria E, Arossa W, Bugiani M, Cesano L, Caropreso A. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy. 1988;61:388–91.

    CAS  PubMed  Google Scholar 

  11. Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, Camargo CA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001490. DOI: 10.1002/14651858.CD001490

  12. Rubin BK, Ramirez O, Ohar JA. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Chest. 1996;109:348–52.

    Article  CAS  PubMed  Google Scholar 

  13. Silverman RA, Osborn H, Runge J, Gallagher EJ, Chiang W, Feldman J, et al. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest. 2002;122(2):489–97.

    Article  CAS  PubMed  Google Scholar 

  14. van der Velden VH. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm. 1998;7(4):229–37.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong-Kek Pang M.D., MRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pang, YK. (2015). Drugs and the Respiratory System. In: Chan, Y., Ng, K., Sim, D. (eds) Pharmacological Basis of Acute Care. Springer, Cham. https://doi.org/10.1007/978-3-319-10386-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-10386-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-10385-3

  • Online ISBN: 978-3-319-10386-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics